Clinical Chemistry, Vol 36, 1530-1530, Copyright © 1990 by the American Association for Clinical Chemistry

Errata

Vol 35:

p 1263: Right column, last paragraph, should read "P >0.05."

pp 1437-1439: Printed Figure 2 should be Figure 5, printed Figure 3 should be Figure 2, printed Figure 4 should be Figure 3, and printed Figure 5 should be Figure 4. The legends were correct as printed.

p 1541: The effects of adding citrate were obscured in the Table in the right column. The correct presentation is as follows:

See table in the PDF file

p 1582: A corrected Figure 1, showing the complementary sequences (instead of the genomic sequences) used for primers 461 and 459, is printed below.

See image in the PDF file

p 1672: Under Subjects, the 157 NIDD subjects were 112 women and 45 men.

Vol 36:

p 26: The illustrations for Figures 3 and 4 should be interchanged.

p 629: The top and bottom panels in the Figure should be interchanged.

p 909: In the Liquid chromatography section, the 0.1 mol/L sodium phosphate buffer was adjusted to pH 6.5 with 5 mL of triethylamine.

p 1159: Lines 4-6 of abstract 968 from Baxter Healthcare Corp., Dade Division, should read as follows: "... polyclonal -hOG antibody-coated tube and detected using a monoclonal anti--hCG antibody labeled with ¹²⁵I. The two-step protocol has a total assay time of 75 mim..."